Harnessing data gathered as part of the National Institutes of Health (NIH) Human Microbiome Project, the co-editor-in-chief of the journal Microbiome, Jacques Ravel, has formed a biotechnology company focused on women’s health.
The company, christened Luca Biologics, has leaned on 15 years of Ravel’s vaginal microbiome research to develop a pipeline of therapeutics designed to treat urinary tract infections (UTI), preterm birth and bacterial vaginosis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,